| pubmed-article:11038295 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C1334088 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C0007102 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C0140080 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C1559154 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:11038295 | lifeskim:mentions | umls-concept:C0680242 | lld:lifeskim |
| pubmed-article:11038295 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11038295 | pubmed:dateCreated | 2000-11-30 | lld:pubmed |
| pubmed-article:11038295 | pubmed:abstractText | Colorectal cancer remains one of the most prevalent malignancies in the United States. Improvement in local disease control is seen when 5-fluorouracil (5-FU) is used in combination with pelvic irradiation for rectal adenocarcinoma. The frequent overexpression of insulin-like growth factor I receptor (IGF-I-R) in rectal adenocarcinoma suggests that inhibition of the signal transduction pathway may be a novel approach to enhance tumor response. This investigation seeks to define the role of IGF-I-R antagonism, using monoclonal antibody alpha-IR3, in augmenting cytotoxicity to adjuvant chemoradiation therapy for adenocarcinoma of the rectum. | lld:pubmed |
| pubmed-article:11038295 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11038295 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11038295 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11038295 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11038295 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11038295 | pubmed:issn | 0022-4804 | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:PangYY | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:BeechD JDJ | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:MadanA KAK | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:PererE SES | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:ShurinAA | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:ZakrisEE | lld:pubmed |
| pubmed-article:11038295 | pubmed:author | pubmed-author:RomegueraKK | lld:pubmed |
| pubmed-article:11038295 | pubmed:copyrightInfo | Copyright 2000 Academic Press. | lld:pubmed |
| pubmed-article:11038295 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11038295 | pubmed:volume | 94 | lld:pubmed |
| pubmed-article:11038295 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11038295 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11038295 | pubmed:pagination | 1-5 | lld:pubmed |
| pubmed-article:11038295 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:meshHeading | pubmed-meshheading:11038295... | lld:pubmed |
| pubmed-article:11038295 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11038295 | pubmed:articleTitle | Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells. | lld:pubmed |
| pubmed-article:11038295 | pubmed:affiliation | Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70118, USA. | lld:pubmed |
| pubmed-article:11038295 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11038295 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11038295 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11038295 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11038295 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11038295 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11038295 | lld:pubmed |
